155 related articles for article (PubMed ID: 16044163)
21. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
22. POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17.
Zhao C; Inoue J; Imoto I; Otsuki T; Iida S; Ueda R; Inazawa J
Oncogene; 2008 Jan; 27(1):63-75. PubMed ID: 17621271
[TBL] [Abstract][Full Text] [Related]
23. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
24. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
25. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
26. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
28. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
Olivier S; Close P; Castermans E; de Leval L; Tabruyn S; Chariot A; Malaise M; Merville MP; Bours V; Franchimont N
Mol Pharmacol; 2006 May; 69(5):1615-23. PubMed ID: 16497877
[TBL] [Abstract][Full Text] [Related]
29. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.
Gavrielides MV; Gonzalez-Guerrico AM; Riobo NA; Kazanietz MG
Cancer Res; 2006 Dec; 66(24):11792-801. PubMed ID: 17178875
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
[TBL] [Abstract][Full Text] [Related]
31. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
32. Maf genes are involved in multiple stress response in human.
Suzuki T; Blank V; Sesay JS; Crawford DR
Biochem Biophys Res Commun; 2001 Jan; 280(1):4-8. PubMed ID: 11162468
[TBL] [Abstract][Full Text] [Related]
33. Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.
Perumal D; Kuo PY; Leshchenko VV; Jiang Z; Divakar SK; Cho HJ; Chari A; Brody J; Reddy MV; Zhang W; Reddy EP; Jagannath S; Parekh S
Cancer Res; 2016 Mar; 76(5):1225-36. PubMed ID: 26873845
[TBL] [Abstract][Full Text] [Related]
34. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
[TBL] [Abstract][Full Text] [Related]
35. ARK5 expression in colorectal cancer and its implications for tumor progression.
Kusakai G; Suzuki A; Ogura T; Miyamoto S; Ochiai A; Kaminishi M; Esumi H
Am J Pathol; 2004 Mar; 164(3):987-95. PubMed ID: 14982852
[TBL] [Abstract][Full Text] [Related]
36. A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression.
Annunziata CM; Hernandez L; Davis RE; Zingone A; Lamy L; Lam LT; Hurt EM; Shaffer AL; Kuehl WM; Staudt LM
Blood; 2011 Feb; 117(8):2396-404. PubMed ID: 21163924
[TBL] [Abstract][Full Text] [Related]
37. ARK5 is a tumor invasion-associated factor downstream of Akt signaling.
Suzuki A; Lu J; Kusakai G; Kishimoto A; Ogura T; Esumi H
Mol Cell Biol; 2004 Apr; 24(8):3526-35. PubMed ID: 15060171
[TBL] [Abstract][Full Text] [Related]
38. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
39. NDR2 acts as the upstream kinase of ARK5 during insulin-like growth factor-1 signaling.
Suzuki A; Ogura T; Esumi H
J Biol Chem; 2006 May; 281(20):13915-21. PubMed ID: 16488889
[TBL] [Abstract][Full Text] [Related]
40. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
Rasmussen T; Knudsen LM; Dahl IM; Johnsen HE
Leuk Lymphoma; 2003 Oct; 44(10):1761-6. PubMed ID: 14692531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
